focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Phantom, fair enough, good to know to be aware of.
Phantom25 - there were major IT problems this afternoon. I started trying to sell at 164 and had three decreasing sell quotes on their app all of which I accepted but all of which were rejected by their app. Eventually got them on the phone and sold. Their website and app were unusable for a large part of the afternoon. Just overloaded, the servers couldn't handle the traffic.
The SP will now find its correct level which is what it is worth when you take covid testing speculation out of the equation. Testing contracts have been awarded left right and centre and the govt have not been straight in their awarding of contracts.
The reality is the in the know CEO ditched lots of shares recently and the opportunities for AVCT within covid testing were a gamble as it stood because lets face it the government aren't straight when it comes to awarding testing contracts.. look at the Randox contract.
Best to take covid and related speculation out of the equation and decide whether to re-invest based on their IP at an appropriate SP. Their IP has plenty of applications. Struggled to sell today at the start of the inevitable plummet because of technical glitches with broker platform, most annoying!
Their pension deficit keeps things low.
On 21 Oct: (Share cast news) - Credit Suisse:
In Defence, they judged BAE Systems to also be "abnormally cheap", arguing that military outlays by governments were likely to continue expanding faster than GDP in an increasingly tri-polar world.
Glad I'm not the only one to do such things!
Despite being dubbed a 'deramper' I have now topped up because speculation aside, their IP is concrete.
outstanding news for investors = CEO sells >30% of his shares when he is the one most likely to know if a jump is imminent?
there's spin and there's spin..
People had been waiting daily for a positive RNS and when an RNS did come it was to say that the CEO had sold >30% of his shares! Understandable that people are a little concerned.
It does send a message. Uncertainty at best I would think.
Yes, the recent drop is bizarre. It'll go back up as they are good company with good fundamentals. As you say, the Woodford case is nothing new and HL have nothing to do with his external failed fund. Anything you buy through HL clearly states that they aren't giving advice and everyone knows this anyway.
I think it's sensible to take some profits along the way to mitigate risk.
You're completely right. They have good intellectual property and there's reason to be hopeful but have to be measured.
If and if and if.. Avacta manage to get their worthy product out the door it will certainly have great mass demand in airport testing, workplaces and schools, unis etc
However, as for "operation moonshot" (wtf) - the cunning plan of testing the entire nation weekly, need it or not, is unfortunately not as cunning as the fox who's just been appointed Professor of Cunning at Oxford University.. which is why they stopped mentioning it very quickly. Unfortunately for "Private Eye" magazine's number crunching section.
From the graphs it appears to have risen to incredibly high values based on the hope of it being the quick big answer to UK covid testing and associated quick profits. This has not happened but the reality of clinical trials, manufacturing and distribution obstacles have become apparent. Great product by the sound of it but a bit concerned about what the more measured share price was back in Feb and Jan before covid.